These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 6314149)
1. Solubilization and partial purification of putative calcium channels labelled with [3H]-nimodipine. Glossmann H; Ferry DR Naunyn Schmiedebergs Arch Pharmacol; 1983 Aug; 323(4):279-91. PubMed ID: 6314149 [TBL] [Abstract][Full Text] [Related]
2. Molecular approach to the calcium channel. Glossmann H; Ferry DR; Goll A; Linn T Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683 [TBL] [Abstract][Full Text] [Related]
3. Identification of putative calcium channels in skeletal muscle microsomes. Ferry DR; Glossmann H FEBS Lett; 1982 Nov; 148(2):331-7. PubMed ID: 6295810 [TBL] [Abstract][Full Text] [Related]
4. Solubilization of the bovine cardiac sarcolemmal binding sites for calcium channel blockers. Ruth P; Flockerzi V; Oeken HJ; Hofmann F Eur J Biochem; 1986 Mar; 155(3):613-20. PubMed ID: 3007137 [TBL] [Abstract][Full Text] [Related]
5. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110. Ferry DR; Goll A; Glossmann H Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337 [TBL] [Abstract][Full Text] [Related]
6. Solubilization and affinity labeling of a dihydropyridine binding site from skeletal muscle: effects of temperature and diltiazem on [3H]dihydropyridine binding to transverse tubules. Kirley TL; Schwartz A Biochem Biophys Res Commun; 1984 Aug; 123(1):41-9. PubMed ID: 6089800 [TBL] [Abstract][Full Text] [Related]
7. Temperature-dependent regulation of d-cis-[3H]diltiazem binding to Ca2+ channels by 1,4-dihydropyridine channel agonists and antagonists. Glossmann H; Linn T; Rombusch M; Ferry DR FEBS Lett; 1983 Aug; 160(1-2):226-32. PubMed ID: 6309565 [TBL] [Abstract][Full Text] [Related]
8. (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle. Goll A; Ferry DR; Striessnig J; Schober M; Glossmann H FEBS Lett; 1984 Oct; 176(2):371-7. PubMed ID: 6092142 [TBL] [Abstract][Full Text] [Related]
9. Identification of voltage operated calcium channels by binding studies: differentiation of subclasses of calcium antagonist drugs with 3H-nimodipine radioligand binding. Glossmann H; Ferry DR; Lübbecke F; Mewes R; Hofmann F J Recept Res; 1983; 3(1-2):177-90. PubMed ID: 6304295 [TBL] [Abstract][Full Text] [Related]
10. Calcium channels: evidence for oligomeric nature by target size analysis. Ferry DR; Goll A; Glossmann H EMBO J; 1983; 2(10):1729-32. PubMed ID: 6315398 [TBL] [Abstract][Full Text] [Related]
11. Target size analysis of skeletal muscle Ca2+ channels. Positive allosteric heterotropic regulation by d-cis-diltiazem is associated with apparent channel oligomer dissociation. Goll A; Ferry DR; Glossmann H FEBS Lett; 1983 Jun; 157(1):63-9. PubMed ID: 6305718 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the binding sites for nimodipine and (-)-desmethoxyverapamil in bovine cardiac sarcolemma. Ruth P; Flockerzi V; von Nettelbladt E; Oeken J; Hofmann F Eur J Biochem; 1985 Jul; 150(2):313-22. PubMed ID: 2990931 [TBL] [Abstract][Full Text] [Related]
13. Purification of a functional receptor for calcium-channel blockers from rabbit skeletal-muscle microsomes. Flockerzi V; Oeken HJ; Hofmann F Eur J Biochem; 1986 Nov; 161(1):217-24. PubMed ID: 3023084 [TBL] [Abstract][Full Text] [Related]
14. Target size analysis and molecular properties of Ca2+ channels labelled with [3H]verapamil. Goll A; Ferry DR; Glossmann H Eur J Biochem; 1984 May; 141(1):177-86. PubMed ID: 6327306 [TBL] [Abstract][Full Text] [Related]
15. Purification of the dihydropyridine receptor of the voltage-dependent Ca2+ channel from skeletal muscle transverse tubules using (+) [3H]PN 200-110. Borsotto M; Barhanin J; Norman RI; Lazdunski M Biochem Biophys Res Commun; 1984 Aug; 122(3):1357-66. PubMed ID: 6089781 [TBL] [Abstract][Full Text] [Related]
16. Human red-blood-cell Ca2+-antagonist binding sites. Evidence for an unusual receptor coupled to the nucleoside transporter. Striessnig J; Zernig G; Glossmann H Eur J Biochem; 1985 Jul; 150(1):67-77. PubMed ID: 2990927 [TBL] [Abstract][Full Text] [Related]
17. Evidence of multiple receptor sites within the putative calcium channel. Ferry DR; Glossmann H Naunyn Schmiedebergs Arch Pharmacol; 1982 Oct; 321(1):80-3. PubMed ID: 6292744 [TBL] [Abstract][Full Text] [Related]
18. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation. Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514 [TBL] [Abstract][Full Text] [Related]
19. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength. Bellemann P; Ferry D; Lübbecke F; Glossmann H Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804 [TBL] [Abstract][Full Text] [Related]
20. Relationship between the stereoselective negative inotropic effects of verapamil enantiomers and their binding to putative calcium channels in human heart. Ferry DR; Glossmann H; Kaumann AJ Br J Pharmacol; 1985 Apr; 84(4):811-24. PubMed ID: 2408698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]